Different peripheral expression patterns of the nicotinic acetylcholine receptor in dementia with Lewy bodies and Alzheimer’s disease

Table 2 Demographic and clinical characteristics

	SW test; p-value	DLB (n = 21)	AD (n = 13)	HC (n = 8)	p-value
Age in years	W = 0.89; p = 0.001	81 (76–84)	79 (64–80)	74.5 (69.5–77.5)	0.060
Females	–	14 (66.6)	7 (53.8)	6 (75.0)	0.586
Education in years	W = 0.69; p = 0.003	8 (5–13)	5 (5–13)	9.5 (6.5–12)	0.464
Disease duration in years	W = 0.90; p = 0.007	4 (3–6.5)	6 (2.5–7.5)	–	0.456
MoCA score	W = 0.91; p = 0.008	11.0 (9.0–19.0)**	12.0 (8.0–15.0)**	29.0 (27.0–30.0)	< 0.001
CDR	–
1		14 (66.7)	8 (61.5)	–	0.761
2		7 (33.3)	5 (38.5)	–

N (%) or median and interquartile range (IQR) are shown when appropriate; SW Shapiro Wilk, W value test and p-value; p-value for Kruskal-Wallis’s test; **p-value <α/3 for Bonferroni multiple testing correction DLB and AD vs HC; MoCA Montreal Cognitive Assessment, CDR Clinical Dementia Rating

ISSN: 1742-4933